Filter
48
Filtered Results: 48
Text search:
Novavax
Featured
Recommendations
3
Language
Document type
Fact sheets
14
Studies & Reports
11
Guidelines
9
No document type
4
Online Courses
3
Strategic & Response Plan
3
Infographics
2
Training Material
1
Resource Platforms
1
Countries / Regions
Ukraine
5
Brazil
4
Russia
4
China
3
Latin America and the Carribbean
3
Middle East and North Africa
3
Mozambique
2
Germany
2
Paraguay
2
Angola
2
Global
1
Guinea-Bissau
1
Authors & Publishers
Publication Years
Category
COVID-19
15
Guidelines
5
Capacity Building
3
Vaccine-preventable Diseases
2
Studies & Reports
2
x MEDBOX Issue Brief & Annual Reports x
1
General Guidelines
1
Policies
1
Information, Education and Communication (IEC)
1
Toolboxes
Fair Allocation & Ethical Aspects
7
Country specific documents
5
Access & Strategy
5
Immunization Guidelines
5
Inactivated COVID-19 Vaccines
4
Online Courses & Resources
3
For Health Worker
3
Communication Material
3
COVAX Initiative
3
Vaccine Hesitancy & Myths
3
Information Refugees Ukraine
3
COVID-19
3
Education material
3
Research
2
Poster & Infographics
2
For General Public & Community
2
For Pregnant Women
2
COVID-19 Vaccination Information
2
Situation Reports & Updates
2
General
2
General Reports
1
Vaccination
1
General
1
Treatment Guidelines
1
Clinical Guidelines
1
Clinical Aspects
1
Scientific & Research Studies
1
COVID-19 Vaccination
1
Genomic sequencing
1
Long COVID/ Post-COVID Syndrome
1
Sputnik V
1
Research & Pipeline
1
Booster Doses
1
Guidelines & Manuals
1
Information, Resources & Websites
1
Psychosocial Support
1
Resource Platforms
1
Health Financing Toolbox
1
General
1
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
ІНФОРМАЦІЙНИЙ ЛИСТ Для вакцинації проти COVID-19 (коронавірусне захворювання 2019 р.) (Первинна вакцинація)
recommended
– з вакциною на білковій основі
(Nuvaxovid® виробництва Novavax)
Станом на: 15 лютого 2022 р. (даний інформаційний лист постійно оновлюється)
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Cor...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
L’ensemble du personnel de santé qui participe au déploiement et à la mise en œuvre de la vaccination contre la COVID-19 doit avoir les connaissances et les compétences requises pour garantir une administration sûre et efficace du vaccin contre la COVID-19. Ce cours de formation fournit des ...
Health workers involved in deployment and implementation of COVID-19 vaccination require vaccine-specific knowledge to ensure safe and efficient vaccine delivery. This training provides key information about COVID-19 vaccines through short instructional videos, vaccine explainers, job aids, topic br...
يحتاج العاملون الصحيون الذين يشاركون في نشر وتنفيذ التطعيم ضد كوفيد-19 إلى معرفة خاصة بكل لقاح لضمان تقديم اللقاحات بشكل آمن وفعال. يوفر هذا التدريب معلومات أساسية ح...
Infoflyer „Impfen hilft. 7 gute Gründe, sich jetzt impfen zu lassen
WHO lists 9th COVID-19 vaccine for emergency use to expand vaccination access in low-income countries, 17 December 2021
As vacinas COVID-19 são eficazes contra novas variantes? O que significa para uma pessoa estar totalmente vacinada? Essa e outras dúvidas estão entre as dúvidas mais frequentes sobre a vacinação contra a COVID-19. Nesta sexta edição você encontrará respostas para essas e outras perguntas.
...
Frequently asked questions on COVID-19 vaccination. Version 6, 12 February 2022
Available in different languages
Available in different languages
Entwicklungen und gegenwärtige Situationen der Covid-19-Impfstoffe
26 July 2021
